Potential for benefits of aprotinin use to outweigh risks in patients undergoing the Ross procedure

Saved in:
Bibliographic Details
Published inThe Journal of thoracic and cardiovascular surgery Vol. 138; no. 1; pp. 233 - 234
Main Authors Barnett, Stephen Arthur, MBBS, FRACS, Liava'a, Matthew, MBBS, Skillington, Peter D., MBBS, FRACS
Format Journal Article
LanguageEnglish
Published New York, NY Mosby, Inc 01.07.2009
Elsevier
Subjects
Adolescent
Adult
Age Factors
Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy
Aortopulmonary Septal Defect - surgery
Aprotinin - administration & dosage
Aprotinin - adverse effects
Biological and medical sciences
Blood Loss, Surgical - prevention & control
Cardiac Surgical Procedures
Cardiology. Vascular system
Cardiothoracic Surgery
Hemostatics - administration & dosage
Hemostatics - adverse effects
Humans
Medical sciences
Middle Aged
Pneumology
Risk Factors
Young Adult
35
25
16
17
Human
Enzyme
Use
Enzyme inhibitor
Patient
Risk
Peptidases
Risk factor
Hydrolases
Anesthesia
Aprotinin
Antifibrinolytic
Circulatory system
Cardiology
Aortic valve
Online AccessGet full text

Cover

More Information
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0022-5223
1097-685X
DOI:10.1016/j.jtcvs.2008.02.066